ASBPW stock

Aspire Biopharma Holdings, Inc. (ASBPW) financials · rev $6.2K

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Aspire Biopharma Holdings, Inc. (ASBPW) rev $6.2K.

Cached annual income statement
LineFY2025FY2024
Revenue$6.20KN/A
Cost of RevenueN/AN/A
Operating Income-$19.4M-$1.21M
Net Income-$24.5M-$12.5M

Cost of Revenue N/A — Withheld: stored cost of revenue does not reconcile with revenue and gross profit for this period.

Cached annual balance sheet
LineFY2025FY2024
Total Assets$1.31M$6.71M
Current Assets$1.31M$45.8K
Cash & Equivalents$1.00M$3.63K
Inventory$253.2KN/A
Total Liabilities$7.69M$15.6M
Current Liabilities$7.59M$15.6M
Shareholders' Equity-$6.38M-$15.6M
Retained Earnings-$27.3M-$24.4M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$4.92M-$2.05M
Investing Cash FlowN/A$13.8M
Financing Cash Flow$5.92M-$11.7M
Net Change in Cash$1.00M-$7.54K
These statements as JSON? API free 100/day

FAQ

What is ASBPW P/E and revenue?

Aspire Biopharma Holdings, Inc. (ASBPW) rev $6.2K.

What is ASBPW revenue?

Aspire Biopharma Holdings, Inc. last cached revenue is $6.20K (FY2025).

Is ASBPW profitable?

Aspire Biopharma Holdings, Inc. last cached net income is -$24.5M (FY2025).

What are ASBPW total assets?

Aspire Biopharma Holdings, Inc. last cached total assets are $1.31M (FY2025).

What is ASBPW free cash flow?

No cached cash-flow row for ASBPW yet.

Not investment advice. Cached statements, not a live tape.